Beckman Coulter Genomics, a provider of DNA Sequencing Services, recently announced accreditation from the College of American Pathologists (CAP). The facility in Danvers, Massachusetts, completed a comprehensive on-site inspection as part of the CAP’s Accreditation Programs. The CAP Laboratory Accreditation Program involves a process of inspections of clinical lab records and quality control procedures and assessments of a lab's staff qualifications, equipment, facilities, safety program, and overall management.
“Beckman Coulter Genomics is proud to achieve accreditation from the College of American Pathologists,” says Tim Anderson, vice president and general manager of genomic services. “CAP accreditation is recognized as the ‘high-water mark’ for laboratory testing. This accomplishment underscores our commitment to advancing healthcare for every person and reinforces our determination to deliver the highest standards of excellence.”
Award of this respected accreditation strengthens Beckman Coulter Genomics’ already strong bioinformatics expertise and extensive experience in study design, guidance and analysis of customer’s crucial clinical samples. “We are pleased to be able to provide our customers a sequencing service which satisfies the exacting requirements of regulatory authorities and will help the facility more quickly move findings from clinical trials into clinical use,” says Stephen Lyle, PhD, laboratory director at Beckman Coulter Genomics.Learn more on the Beckman Coulter Genomics website